Suppression of murine autoimmune myocarditis achieved with direct renin inhibition.

[1]  M. Matsuzaki,et al.  Diverse stage-dependent effects of glucocorticoids in a murine model of viral myocarditis. , 2013, Journal of cardiology.

[2]  R. Carey,et al.  Subcellular characteristics of functional intracellular renin–angiotensin systems , 2012, Peptides.

[3]  M. Isobe,et al.  Impaired post-infarction cardiac remodeling in chronic kidney disease is due to excessive renin release , 2012, Laboratory Investigation.

[4]  M. Rudin,et al.  Cooperation of Th1 and Th17 cells determines transition from autoimmune myocarditis to dilated cardiomyopathy , 2012, European journal of immunology.

[5]  Sandeep Sagar,et al.  Myocarditis , 2012, The Lancet.

[6]  W. Savino,et al.  AT1 receptor-mediated angiotensin II activation and chemotaxis of T lymphocytes. , 2011, Molecular immunology.

[7]  Kenji Suzuki,et al.  Telmisartan ameliorates experimental autoimmune myocarditis associated with inhibition of inflammation and oxidative stress. , 2011, European journal of pharmacology.

[8]  I. Garrelds,et al.  Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats , 2010, Journal of hypertension.

[9]  K. Nitta,et al.  Dynamic Observation of Mechanically-Injured Mouse Femoral Artery Reveals an Antiinflammatory Effect of Renin Inhibitor , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[10]  K. Kataoka,et al.  Aliskiren Enhances the Protective Effects of Valsartan Against Cardiovascular and Renal Injury in Endothelial Nitric Oxide Synthase–Deficient Mice , 2009, Hypertension.

[11]  D. Harrison,et al.  Regulation of T-cell function by endogenously produced angiotensin II. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[12]  C. Tschöpe,et al.  Renin Inhibition Improves Cardiac Function and Remodeling After Myocardial Infarction Independent of Blood Pressure , 2008, Hypertension.

[13]  R. Charnigo,et al.  Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. , 2008, The Journal of clinical investigation.

[14]  U. Eriksson,et al.  CD11b+ Monocytes Abrogate Th17 CD4+ T Cell-Mediated Experimental Autoimmune Myocarditis1 , 2008, The Journal of Immunology.

[15]  R. Schmieder,et al.  Renin-angiotensin system and cardiovascular risk , 2007, The Lancet.

[16]  A. Takakura,et al.  Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation. , 2007, Journal of the American Society of Nephrology : JASN.

[17]  Yizhi Yu,et al.  Increased expression of CCR5 in experimental autoimmune myocarditis and reduced severity induced by anti-CCR5 monoclonal antibody. , 2007, Journal of molecular and cellular cardiology.

[18]  C. Ferrario,et al.  Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. , 2006, The American journal of cardiology.

[19]  M. Isobe,et al.  A cyclooxygenase-2 inhibitor alters Th1/Th2 cytokine balance and suppresses autoimmune myocarditis in rats. , 2006, Journal of molecular and cellular cardiology.

[20]  H. Katus,et al.  Critical Role for Monocyte Chemoattractant Protein-1 and Macrophage Inflammatory Protein-1α in Induction of Experimental Autoimmune Myocarditis and Effective Anti–Monocyte Chemoattractant Protein-1 Gene Therapy , 2005, Circulation.

[21]  M. Wellner,et al.  Aliskiren, a Human Renin Inhibitor, Ameliorates Cardiac and Renal Damage in Double-Transgenic Rats , 2005, Hypertension.

[22]  Lukas Hunziker,et al.  Dendritic cell–induced autoimmune heart failure requires cooperation between adaptive and innate immunity , 2003, Nature Medicine.

[23]  S. Marsch,et al.  Interleukin-6–Deficient Mice Resist Development of Autoimmune Myocarditis Associated With Impaired Upregulation of Complement C3 , 2003, Circulation.

[24]  G. Wuerzner,et al.  Angiotensin II Suppression in Humans by the Orally Active Renin Inhibitor Aliskiren (SPP100): Comparison With Enalapril , 2002, Hypertension.

[25]  N. Rose,et al.  From infection to autoimmunity. , 2001, Journal of autoimmunity.

[26]  D. Ganten,et al.  Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research , 2001, Journal of Molecular Medicine.

[27]  D. Dostal.  The cardiac renin–angiotensin system: novel signaling mechanisms related to cardiac growth and function , 2000, Regulatory Peptides.

[28]  P. Mannon,et al.  Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. , 1999, The Journal of clinical investigation.

[29]  C. Kawai,et al.  From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. , 1999, Circulation.

[30]  ChuichiKawai.  From Myocarditis to Cardiomyopathy: Mechanisms of Inflammation and Cell Death , 1999 .

[31]  J. Penninger,et al.  Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice. , 1996, The Journal of clinical investigation.

[32]  A. Herskowitz,et al.  Concepts of autoimmunity applied to idiopathic dilated cardiomyopathy. , 1993, Journal of the American College of Cardiology.

[33]  M. Ruzicka,et al.  The Renin‐Angiotensin System and Volume Overload‐Induced Cardiac Hypertrophy in Rats Effects of Angiotensin Converting Enzyme Inhibitor Versus Angiotensin II Receptor Blocker , 1993, Circulation.

[34]  O. Costerousse,et al.  Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. , 1993, The Biochemical journal.

[35]  J. Higaki,et al.  Role of Cardiac Angiotensin II in Isoproterenol‐Induced Left Ventricular Hypertrophy , 1992, Hypertension.

[36]  Y. Yazaki,et al.  Expression of Perforin in Infiltrating Cells in Murine Hearts With Acute Myocarditis Caused by Coxsackievirus B3 , 1991, Circulation.

[37]  K. Beisel,et al.  Cardiac myosin induces myocarditis in genetically predisposed mice. , 1987, Journal of immunology.